How a LIMS Is Priced, and What Per-Seat Does to a Lab
Breaks a quote into licensing, implementation, hosting and support, explains what drives the number up or down, and gives realistic ranges by lab size.
Archive
Showing 10 of 109 items
Breaks a quote into licensing, implementation, hosting and support, explains what drives the number up or down, and gives realistic ranges by lab size.
Why lab instrument integrations that passed acceptance fail a year later: renamed fields, retired accounts, silent changes. What to agree before connecting.
What a laboratory execution system (LES) records that a signed SOP cannot, why the method must lock while it runs, and when a notebook is no longer enough.
Types of LIMS cut by what the lab tracks, not by vendor packaging: sample, patient, experiment, batch or machine. Which type you are, and what to ask.
Regulatory shifts landing in 2026, the frameworks behind them, the financial case for getting ahead, and a phased roadmap from gap analysis to accreditation.
LIMS validation is owned by the lab, not the vendor. What Part 11, Annex 11, ISO 17025, GAMP 5 and FDA software assurance ask for, and where projects fail.
EPA proposed moving PFAS treatment compliance to 2031, but initial monitoring results are still due April 26, 2027. What systems and labs must complete first.
Compares cloud and on-premises hosting on cost, deployment speed, accessibility, scalability and data control, with a checklist for deciding between them.
Where paper custody forms break down past 1000 samples a month, plus sample ID standards, transfer controls and a five-step path to automating the process.
The federal date slipped to 2028 but Walmart and Kroger set their own supplier deadlines, and the traceability gap most food suppliers miss sits in the lab.